Market Tracker

11/21 6:05pm ET

Actavis PLC (NYSE:ACT)

259.75
Data as of Nov 21
 +1.26 / +0.49%
Today’s Change
156.40
Today|||52-Week Range
270.34
+54.61%
Year-to-Date

Today’s Trading

Previous close258.49
Today’s open262.83
Day’s range257.02 - 262.83
Volume4,512,452
Average volume (3 months)2,772,282
Market cap$68.8B
Dividend yield--
Data as of 4:05pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)-793.42%
Earnings growth (this year)+42.65%
Earnings growth (next 5 years)+18.50%
Revenue growth (last year)+46.71%
P/E ratioNM
Price/Sales2.75
Price/Book4.75

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.03+0.07%
LLYEli Lilly and Co+0.56+0.84%
AGNAllergan Inc-1.11-0.53%
CELGCelgene Corp+0.85+0.79%
Data as of 4:02pm ET, 11/21/2014

Financials

Next reporting dateFebruary 17, 2015
EPS forecast (this quarter)$3.49
Annual revenue (last year)$8.7B
Annual profit (last year)-$750.4M
Net profit margin-8.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts